Omega-3, Autism Spectrum Disorder (ASD)
ConditionASD
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-17
SponsorChina Medical University Hospital
About this trial
This is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in youth with autism spectrum disorder (ASD).
Eligibility criteria
Qualifiers
diagnosis of DSM5 ASD made by child and adolescent psychiatrist
age 6-17 years-old at the time of enrolment
no pharmacotherapy or non-pharmacotherapy adjustment within the past 4 weeks,
Signed informed consent.
Disqualifiers
comorbid other psychiatric disorders, including schizophrenia or affective mood disorder (Bipolar and Major Depressive Disorder), or substance use disorder
comorbid physical disorders, such as thyroid dysfunction, cerebral palsy, coagulation disorders
currently using omega-3 supplements or probiotics
allergy to omega-3.
Trial design
Treatments tested in this trial
- Omega-3
- Placebo
Treatment groups
50 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov